Biopharma Co. Hit With Suit Over Directors' 'Excessive' Pay
Ultragenyx Pharmaceutical Inc. was hit with a derivative stockholder suit in Delaware Chancery Court on Wednesday, claiming the company's board is being paid "excessive" salaries, even as the company continues to...To view the full article, register now.
Already a subscriber? Click here to view full article